Upcoming Events

Dr. Robert A. Harrington is a cardiologist and the Arthur L. Bloomfield Professor and Chairman of the Department of Medicine (DOM) at Stanford University. He received his BA in English at the College of the Holy Cross, Worcester, MA and his MD from Tufts University School of Medicine, Boston MA. He did his internship, residency and served as the chief resident in internal medicine at the University of Massachusetts Medical Center. He trained in cardiology, interventional cardiology, and clinical research at Duke University Medical Center. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease, building local, national and international collaborations for the efficient conduct of innovative clinical research and trying to better understand and improve upon the methodology of clinical research. He is the author of more than 560 peer-reviewed manuscripts, reviews, book chapters, and editorials, and serves on a number of highly regarded associations, boards, committes, and journals. In 2016, he was named a Master of the American College of Cardiology. He was awarded the AHA’s Clinical Research Prize in 2017.

Dr. Ceaser is a Stanford Neuroscience Institute postdoctoral research fellow in the Department of Psychiatry and Behavioral Sciences. From Washington University, he earned his PhD in psychology and completed his internship at the University of Arizona. The goal of his research is to better understand the neural mechanisms of complex cognition, like working memory and executive control, particularly in the context of psychiatric diseases like psychosis. Dr. Ceaser is passionate about improving representation and inclusivity. He was born in New Orleans, raised in Atlanta, is a veteran of the US Navy, and is 1st Gen.

Iris. C. Gibbs, MD, FACR is the Associate Dean of MD Admissions at Stanford Medicine and Professor of Radiation Oncology. She is committed to recruiting a diverse student body to fulfill Stanford’s mission to be a premier research-intensive medical school that improves health through leadership, diversity, collaboration, and innovation in patient care, education, and research. Dr. Gibbs earned her MD degree at Stanford School of Medicine and also completed her Radiation Oncology residency training at Stanford. Her clinical and research areas of expertise include pediatric brain tumors, adult brain tumors, functional radiosurgery, and spinal radiosurgery. She is a Fellow of the American Board of Radiology and a board certified radiation oncologist, and is active in the National Medical Association where she currently serves as Chair of the Section on Radiology and Radiation Oncology, and is on the Editorial Board of the Journal of the NMA. As the former Co-Director of the Stanford CyberKnife Radiosurgery program for over a decade, Dr. Gibbs helped to build world-renowned clinical programs in innovative radiation treatment of central nervous system tumors and robotic radiosurgery. Dr. Gibbs is a dedicated educator who has served as the former Director of Education and Residency Program Director at Stanford’s Department of Radiation Oncology.

Dr. Molina is Chief Medical Officer at Sutro Biopharma. Previously, he was Vice President, Oncology Scientific Innovation at Janssen R & D (Johnson and Johnson, JNJ). While at JNJ he was responsible for the clinical development and New Drug Application for abiraterone (Zytiga(r)), which is now approved for metastatic prostate cancer in more than 100 countries. He was Chief Medical Officer/EVP at Cougar Biotechnology, which was acquired by JNJ in 2009. Arturo also worked at IDEC, then Biogen-IDEC, ultimately becoming Head, Oncology Clinical Development. In collaboration with Genentech, he led the clinical Supplemental Biologics License Application (sBLA) filing activities resulting in FDA approval of Rituxan(r) in two first-line indications in 2006: follicular lymphoma and diffuse B-cell lymphoma. From 1991-2002, Dr. Molina was a faculty physician in Hematology/Bone Marrow Transplantation and Medical Oncology/Therapeutics Research at the City of Hope (COH) Comprehensive Cancer Center, where he became an Adjunct Professor, member of the COH Medical Group Board of Directors and President-Elect of the COH Medical Staff. Arturo received his MD and MS (Physiology) from Stanford University, and completed residency in Internal Medicine and fellowships in Medical Oncology, Biological Science, and Bone Marrow Transplantation, all at Stanford. Arturo was an undergraduate at the University of Texas at Austin where he received a BS in Zoology (Honors) and BA in Psychology (High Honors).

Rosyli immigrated from Mexico and was raised in Victorville, CA. She attended a junior college before attending CSU, San Bernardino, where she completed her undergraduate and graduate degree in Biology as a DACA student. She is the first in her family to complete a graduate degree and attend a professional school. Only one or two people in her family (besides her father) has attended college. She is interested in Oncology, educational and health disparities, and clinical trial development. In her free time, Rosyli likes to go to street fairs, hike, watch movies, and play soccer and tennis.